$2.66 0.06 (+2.31%)
2/10/2012 4:00 PM

Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Featured Broker Partners


Advertisement